Search filters

Filters
Clear All

Phase

  • 18
  • 63
  • 42
  • 80
  • 13
  • 93
  • 13
  • 581
  • 934
  • 404
  • 12
  • 45
  • 881
  • 931
  • 7
  • 20
  • 918

Found 938 All Conditions trials

A listing of All Conditions medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Sort by:
ANDROMEDA-SHOCK-2 Trial
18 years - 99 years
All genders
Septic shock is a disease of the circulatory system representing a complication of serious infections, and is associated with a very high mortality, since around 1/3 of patients with this condition die. This disease produces a series of alterations in the body, including failure of the heart, kidneys, liver, among …
UPCC 12420 A Phase 2, Open- Label, Single-Arm, Multicohort, Multicenter Trial to Evaluate the Efficacy and Safety of JCAR017 in Adult Subjects with Relapsed or Refractory Indolent B-Cell Non-Hodgkin Lymphoma (NHL)
18 years or above
All genders
Phase 2
Interventional
This study investigates the efficacy and safety of an investigational medication in adults with relapsed or refractory indolent B-cell Non-Hodgkin Lymphoma (NHL), specifically follicular lymphoma (FL) and marginal zone lymphoma (MZL). The purpose of this study is to understand how well the investigational medication works in treating these types of …
The NICU Antibiotics and Outcomes Trial (NANO)
99 years or below
All genders
The goal of the NANO trial is to study the longstanding clinical practice of empirically administering intravenous antibiotics to extremely low birthweight (ELBW) infants in the first days of life. In this 802-subject multicenter placebo-controlled randomized clinical trial, the hypothesis to be tested is that the incidence of adverse outcomes …
Cardiac Amyloidosis Registry Study ("CARS")
18 years - 89 years
All genders
Observational
This registry is a retrospective observational, multi-center study designed to collect data and analyze data retrospectively on patients with AL or TTR cardiac amyloidosis. Subjects under the care of the local investigator will be identified and consented. No patient visits or patient procedures will be required for the purpose of …
UPCC 09821 Phase 1/2 Study of Regn4336 (A Psmaxcd3 Bispecific Antibody) Administered Alone or in Combination with Cemiplimab in Patients with Metastatic Castration-Resistant Prostate Cancer
18 years or above
Male
Phase 1/2
Interventional
This study investigates the use of an investigational medication for individuals with metastatic castration-resistant prostate cancer. The purpose of this study is to understand the safety and effectiveness of the investigational medication when given alone or in combination with another investigational drug. The study is divided into two parts: Part …
Pharmacogenetics and Variability In Drug Exposure and Clinical Response to Corticosteroids in Severe BPD
1 years or below
All genders
Observational
This observational study will follow infants born with a gestational age of less than 32 weeks requiring positive pressure ventilation and planned clinical treatment with corticosteroids for bronchopulmonary dysplasia.
The Diaphragmatic Initiated Ventilatory Assist (Diva) Trial
99 years or below
All genders
Interventional
DIVA is a pragmatic randomized clinical trial (RCT) to determine: among (P) preterm infants born 24-27 6/7 weeks gestation undergoing extubation from mechanical ventilation, whether (I) Non-invasive neurally adjusted ventilatory assist (NIV-NAVA) (C) compared with Non-synchronized nasal intermittent positive pressure ventilation (NS-NIPPV), will reduce the incidence of (O) extubation failure …
UPCC 16121 Saci-IO TNBC: Randomized Phase II Study of Sacituzumab Govitecan With or Without Pembrolizumab in PD-L1-Negative Metastatic Triple Negative Breast Cancer (TNBC)
18 years or above
All genders
Phase 2
Interventional
This study investigates the safety and effectiveness of an investigational treatment for patients with metastatic triple-negative breast cancer (TNBC) that is PD-L1-negative. The purpose of this study is to evaluate Sacituzumab Govitecan, alone or in combination with Pembrolizumab, in delaying the progression of this cancer.Participants will undergo various study procedures, …
UPCC 02110 I-SPY 2 TRIAL (Investigation of Serial Studies to Predict Your Therapeutic Response with Imaging And Molecular Analysis 2)
18 years or above
All genders
Phase 2
Interventional
This study investigates personalized medicine approaches to determine which investigational medications are most effective for different types of breast cancer tumors. The purpose is to identify early indicators of treatment response, such as tumor analysis before surgery using MRI images, tissue, and blood samples, to predict treatment success.Participants will undergo …
UPCC 10420 Tissue Collection for Multiple Myeloma Research
18 years - 99 years
All genders
Interventional
The primary purpose of this research study is to obtain specimens (blood, bone marrow, and other tissues) for research about multiple myeloma and related diseases.
431 - 440 of 938